voriconazole has been researched along with Candidiasis, Genital in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 2 (13.33) | 29.6817 |
| 2010's | 4 (26.67) | 24.3611 |
| 2020's | 8 (53.33) | 2.80 |
| Authors | Studies |
|---|---|
| Adelson, ME; Chadwick, SG; Gygax, SE; Mordechai, E; Self, MJ; Trama, JP; Vermitsky, JP; Zimmerman, JA | 1 |
| Abd-Elsalam, WH; Abouelatta, SM; Nagy, YI | 1 |
| Chen, H; Chen, X; Deng, S; Hong, N; Hu, D; Lei, Y; Liao, W; Tsui, KM; Wu, G; Yan, L; Yu, N; Zhang, H; Zhao, R | 1 |
| Cui, F; Kan, S; Li, X; Liu, W; Pang, Q | 1 |
| Dean, G; Fearnley, N; Morris, GC; Soni, S; Sundaram, S; Wilson, JD | 1 |
| An, R; Chen, Y; Cui, F; Cui, M; Fan, S; Kan, S; Li, D; Li, P; Li, X; Liang, X; Liao, Q; Liu, W; Lv, G; Mei, H; Pang, Q; Qiao, Q; Song, N; Xiong, Z; Zhang, M; Zheng, H | 1 |
| AlFouzan, W; Anastasiadis, E; Dhar, R; El Chaar, M; Ghaddar, A; Ghaddar, N; Halimeh, R; Yusef, H | 1 |
| Afeke, I; Agede, CY; Asiamah, EA; Deku, JG; Dodoo, C; Kasu, ES; Korbuvi, J; Kwawu, GS; Louis, B; Mbroh, HK; Mensah, P; Opintan, JA; Osei, GY; Tampuori, J; Waikhom, SD | 1 |
| Bajalan, Z; Hemmat, N; Javadi, A; Mohammadi, F | 1 |
| Faryal, R; Shah, AA; Siddiqui, MT; Tasneem, U | 1 |
| Abebaw, Y; Bitew, A | 1 |
| Chowdhary, A; Kathuria, S; Khan, N; Kumar, DA; Meis, JF; Muralidhar, S; Prakash, A; Randhawa, HS; Sharma, C; Singh, PK; Wankhede, S | 1 |
| Asticcioli, S; Daturi, R; Matti, C; Nucleo, E; Pagani, L; Sacco, L; Zara, F | 1 |
| Cid Lama, A; Crespo Erchiga, V; Fernández Ballesteros, MD; Gomez-Moyano, E; Lova Navarro, M; Vera Casaño, A | 1 |
| Baquero, F | 1 |
15 other study(ies) available for voriconazole and Candidiasis, Genital
| Article | Year |
|---|---|
Antifungal resistance of Candida glabrata vaginal isolates and development of a quantitative reverse transcription-PCR-based azole susceptibility assay.
Topics: Antifungal Agents; Azoles; Candida glabrata; Candidiasis, Vulvovaginal; Drug Resistance, Fungal; Female; Fluconazole; Fungal Proteins; Gene Expression Regulation, Fungal; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests; Reverse Transcriptase Polymerase Chain Reaction; Sensitivity and Specificity; Up-Regulation; Vagina | 2008 |
Tailoring thixotropic mixed-lipid nanoconstructs of voriconazole for the management of Vulvovaginal candidiasis: Formulation, statistical optimization,
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis, Vulvovaginal; Chemistry, Pharmaceutical; Dose-Response Relationship, Drug; Drug Carriers; Drug Liberation; Drug Stability; Female; Lipids; Nanoparticles; Particle Size; Random Allocation; Rats; Rats, Wistar; Viscosity; Voriconazole | 2021 |
Genotyping and Drug Resistance Profile of Clinical Isolates of Candida albicans from Vulvovaginal Candidiasis in the Eastern China.
Topics: Anidulafungin; Antifungal Agents; Candida; Candida albicans; Candidiasis, Vulvovaginal; Drug Resistance, Fungal; Female; Fluconazole; Genotype; Humans; Microbial Sensitivity Tests; Voriconazole | 2022 |
Biased Genotype Distributions of Candida albicans Strains Associated with 649 Clinical Vulvovaginal Candidiasis in China.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis, Vulvovaginal; Drug Resistance, Fungal; Female; Fluconazole; Genotype; Humans; Itraconazole; Microbial Sensitivity Tests; Voriconazole | 2022 |
Outcomes and experiences of using oral voriconazole with or without concomitant topical agents to treat refractory vulvovaginal yeast infections.
Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Female; Fluconazole; Humans; Retrospective Studies; Saccharomyces cerevisiae; Voriconazole | 2022 |
In Vitro Antifungal Activity of Azoles and Other Antifungal Agents Against Pathogenic Yeasts from Vulvovaginal Candidiasis in China.
Topics: Antifungal Agents; Azoles; Candida; Candida albicans; Candida glabrata; Candidiasis, Vulvovaginal; Caspofungin; Female; Fluconazole; Humans; Itraconazole; Voriconazole | 2023 |
Prevalence and antifungal susceptibility of Candida albicans causing vaginal discharge among pregnant women in Lebanon.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida albicans; Candida glabrata; Candidiasis, Vulvovaginal; Cross-Sectional Studies; Drug Resistance, Fungal; Female; Fluconazole; Follow-Up Studies; Humans; Incidence; Infant, Newborn; Itraconazole; Lebanon; Microbial Sensitivity Tests; Pregnancy; Prevalence; Vaginal Discharge; Voriconazole | 2020 |
Prevalence of vulvovaginal candidiasis among pregnant women in the Ho municipality, Ghana: species identification and antifungal susceptibility of Candida isolates.
Topics: Adolescent; Adult; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida parapsilosis; Candidiasis, Vulvovaginal; Cross-Sectional Studies; Female; Fluconazole; Ghana; Humans; Microbial Sensitivity Tests; Pichia; Pregnancy; Pregnancy Complications; Pregnant Women; Prevalence; Prospective Studies; Vaginal Smears; Voriconazole; Young Adult | 2020 |
Analysis of Biofilm-Related Genes and Antifungal Susceptibility Pattern of Vaginal
Topics: Adult; Amphotericin B; Antifungal Agents; Biofilms; Biomass; Candida albicans; Candida glabrata; Candidiasis, Vulvovaginal; Drug Resistance, Fungal; Female; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Middle Aged; Polymorphism, Restriction Fragment Length; Vagina; Virulence; Voriconazole; Young Adult | 2021 |
Prevalence and antifungal susceptibility of Candida species in a tertiary care hospital in Islamabad, Pakistan.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida parapsilosis; Candida tropicalis; Candidiasis; Candidiasis, Vulvovaginal; Child; Child, Preschool; Cross-Sectional Studies; Drug Resistance, Fungal; Female; Fluconazole; Humans; Infant; Infant, Newborn; Inpatients; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Outpatients; Pakistan; Prevalence; Prospective Studies; Respiratory Tract Infections; Tertiary Care Centers; Urinary Tract Infections; Voriconazole; Young Adult | 2017 |
Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern.
Topics: Adolescent; Adult; Antifungal Agents; Candida albicans; Candidiasis, Vulvovaginal; Caspofungin; Cross-Sectional Studies; Drug Resistance, Fungal; Ethiopia; Female; Fluconazole; Flucytosine; Humans; Micafungin; Microbial Sensitivity Tests; Middle Aged; Prevalence; Reproductive Tract Infections; Sexual Partners; Voriconazole; Young Adult | 2018 |
Candida nivariensis as an etiologic agent of vulvovaginal candidiasis in a tertiary care hospital of New Delhi, India.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candidiasis, Vulvovaginal; DNA, Fungal; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Genotype; Humans; India; Itraconazole; Microbial Sensitivity Tests; Nitriles; Phenotype; Phylogeny; Polymerase Chain Reaction; Pyridines; Pyrimidines; Sequence Analysis, DNA; Tertiary Care Centers; Triazoles; Voriconazole; Young Adult | 2013 |
Trends in frequency and in vitro antifungal susceptibility patterns of Candida isolates from women attending the STD outpatients clinic of a tertiary care hospital in Northern Italy during the years 2002-2007.
Topics: Antifungal Agents; Candida; Candidiasis, Vulvovaginal; Drug Resistance, Fungal; Female; Fluconazole; Humans; Italy; Microbial Sensitivity Tests; Outpatient Clinics, Hospital; Prevalence; Pyrimidines; Recurrence; Triazoles; Vagina; Voriconazole | 2009 |
[Efficacy of voriconazole treatment in chronic vulvovaginal candidosis due to Candida glabrata].
Topics: Adult; Antifungal Agents; Candida glabrata; Candidiasis, Vulvovaginal; Cesarean Section; Drug Evaluation; Drug Resistance, Multiple, Fungal; Female; Fluconazole; Humans; Microbial Sensitivity Tests; Pregnancy; Puerperal Disorders; Pyrimidines; Recurrence; Species Specificity; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2013 |
[Antifungal drugs: the new frontier].
Topics: Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Candidiasis, Vulvovaginal; Caspofungin; Drug Resistance, Microbial; Echinocandins; Female; Fungi; Humans; Lipopeptides; Male; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Research; Triazoles; Trypanocidal Agents; Voriconazole | 1998 |